52-104 Week Off-therapy Second Extension to Study CSPP100A2365

NCT01420068 · clinicaltrials.gov ↗
COMPLETED
Status
106
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Noden Pharma